Contact Person: Jon Schorah
Delaware Corporate Center II, 2 Righter Parkway, Suite 205
Wilmington DE 19803, United States
Synchrogenix partners with pharmaceutical, biotech, and medical device companies to develop documents for submission to regulatory agencies worldwide from pre-IND/IMPD through post-approval. We have chosen to specialize because regulatory writing is an expertise and an integral part of the drug development process and each program's legacy.